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Abstract
Introduction Development of acute kidney injury (AKI) during
the perioperative period is associated with increases in
morbidity and mortality. Our aim was to evaluate the incidence
and determinants of postoperative AKI after major noncardiac
surgery in patients with previously normal renal function.
Methods This retrospective cohort study was carried out in the
multidisciplinary Post-Anaesthesia Care Unit (PACU) with five
intensive care beds. The study population consisted of 1166
patients with no previous renal insufficiency who were admitted
to these intensive care unit (ICU) beds over 2 years. After
admission patients were followed for the development of AKI,
defined as proposed by The Acute Kidney Injury Network
(increment of serum creatinine [greater than or equal to] 0.3 mg/
dL or 50% from baseline within 48 hours or urine output < 0.5
mL/kg/hr for > 6 hours despite fluid resuscitation when
applicable). Patient preoperative characteristics, intraoperative
management and outcome were evaluated for associations with
acute kidney injury using an univariate and multiple logistic
regression model.
Results A total of 1597 patients were admitted to the PACU
and of these, 1166 met the inclusion criteria. Eighty-seven
patients (7.5%) met AKI criteria. Univariate analysis identified
age, American Society of Anesthesiologists (ASA) physical
status, emergency surgery, high risk surgery, ischemic heart
disease, congestive heart disease and Revised Cardiac Risk
Index (RCRI) score as independent preoperative determinants
for AKI in the postoperative period. Multivariate analysis
identified ASA physical status, RCRI score, high risk surgery
and congestive heart disease as preoperative determinants for
AKI in the postoperative period. Patients that developed AKI had
higher Simplified Acute Physiology Score (SAPS) II and Acute
Physiology and Chronic Health Evaluation (APACHE) II, higher
PACU length of stay (LOS), higher PACU mortality, higher
hospital mortality and higher mortality at 6 months follow-up. AKI
was an independent risk factor for hospital mortality (OR 3.12,
95% CI 1.41 to 6.93, P = 0.005).
Conclusions This study shows that age, emergency and high
risk surgery, ischemic heart disease, congestive heart disease,
ASA physical status and RCRI score were considered risk
factors for the development of AKI, in patients needing intensive
care after surgery. AKI has serious impact on PACU length of
stay and mortality. AKI was an independent risk factor for
hospital mortality.
Introduction
Acute kidney injury (AKI) is commonly seen in the perioperative
period and in the intensive care unit (ICU). It is associated with
a prolonged hospital stay and high morbidity and mortality [1-
6].
Acute renal failure is a complex disorder that occurs in a variety
of settings with clinical manifestations ranging from a minimal
elevation in serum creatinine to anuric renal failure.
To date, there is no universally accepted definition for acute
kidney dysfunction. Varying terms, including acute renal fail-
ure, renal insufficiency, kidney injury, and renal impairment,
and various definitions (e.g. percent or absolute increments of
creatinine, or decrements of urine output) have been used in
previous publications. Furthermore the term acute kidney
injury has been put forth as the preferred nomenclature to
replace acute renal failure with the understanding that the
AKI: acute kidney injury; AKIN: Acute Kidney Injury Network; APACHE II: Acute Physiology and Chronic Health Evaluation; ASA-PS: American Society 
of Anesthesiologists physical status; BMI: body mass index; CI: confidence interval; ICU: intensive care unit; LOS: length of stay; OR: odds ratio; 
PACU: post anesthesia care unit; RCRI: Revised Cardiac Risk Index; RIFLE: Risk, Injury, Failure, Loss and End-stage kidney disease; SAPS: Simpli-
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spectrum of AKI is broad and includes different degrees of
severity.
We used the definition of AKI proposed by the Acute Kidney
Injury Network (AKIN) that was formed to facilitate the devel-
opment and execution of initiatives to ensure the best out-
comes for patients with AKI [7]. As an initial step the AKIN
group proposed the term acute kidney injury to reflect the
entire spectrum of acute renal failure and developed interim
diagnostic and staging criteria for AKI. The diagnostic criteria
require a 0.3 mg/dL or 50% or higher change in serum creat-
inine (Scr) from baseline or a reduction on urine output of less
than 0.5 ml/kg/hr over a six-hour interval, within a 48-hour
period, following adequate volume resuscitation. These crite-
ria were based on accumulating evidence that even small alter-
ations in Scr are associated with severe consequences [2,4,8-
10].
AKI occurs in approximately 1 to 5% of all hospitalized patients
and is increasingly prevalent [1,11]. It is devastating to both
patients and anesthesiologists, when patients with no evi-
dence of renal dysfunction preoperatively develop AKI after
surgery. Various studies have been published determining AKI
incidence in specific patient populations: hospitalized patients
[12], ICU patients [13,14], after cardiac surgery [15,16],
patients with sepsis, and patients on renal replacement ther-
apy [17,18].
Although predictors of postoperative acute renal failure after
noncardiac surgery in patients with previously normal renal
function had been studied previously [1], little is known about
AKI predictors using the AKIN criteria.
The purpose of our study was to evaluate the incidence and
determinants of the development of AKI in the immediate post-
operative period in patients with previous normal renal func-
tion.
Materials and methods
The Institutional Review Board of the Hospital de São João
approved the study and waived the requirement for informed
consent for the retrospective review of medical records. This
retrospective cohort study was carried out at the Hospital São
João, a 1124-bed community teaching hospital in Porto, Por-
tugal, in the multidisciplinary post-anesthesia care unit
(PACU). The PACU includes a surgical ICU with five beds in
which surgical critically ill patients are admitted and closely
monitored and treated.
All postoperative patients admitted to the surgical ICU area of
the PACU, aged 18 years or more, who underwent scheduled
or emergency noncardiac surgery between 1 March 2006 and
1 March 2008 with an overnight admission and more than 12
hours of PACU stay were eligible for the study. Patients were
included only if a preoperative Scr within 30 days of the oper-
ative data was available. Patients readmitted during the study
period were enrolled in relation to the time of their first admis-
sion. The PACU admits all surgical patients, with the exception
of cardiothoracic patients.
Exclusion criteria were pre-existing renal dysfunction requiring
renal replacement therapy or a preoperative Scr higher than
1.6 mg/dL for men and 1.4 mg/dL for women. Preoperative
Scr values were defined as the most recent Scr (mg/dL) meas-
ured within 30 days of the surgery.
The primary outcome was development of AKI during PACU
stay.
Patients were classified as having AKI if they had an increment
of Scr of 0.3 mg/dL or higher or 50% or more increase within
any 48-hour interval and/or an episode of less than 0.5 mL/kg/
hr urine output for more than six hours despite fluid challenge
of 500 mL or more normal saline, when appropriate.
The following variables were recorded on admission to the
PACU: age, gender, body mass index (BMI), American Society
of Anesthesiologists physical status (ASA-PS), preadmission
comorbilities (specifically ischemic heart disease, congestive
heart failure, cerebrovascular disease, hypertension, diabetes,
hyperlipidemia), duration of anesthesia, type of anesthesia,
core temperature, and troponin I blood levels.
Intraoperative data recorded for each case included adminis-
tration of crystalloids, colloids, erythrocytes, and fresh frozen
plasma.
Intraoperative and PACU data were collected as well as hos-
pital length of stay (LOS). Mortality was recorded for all
patients. The Acute Physiology and Chronic Health Evaluation
(APACHE) II [19] and the Simplified Acute Physiology Score
(SAPS) II [20] were calculated using standard methods.
Adapting a classification scheme developed by Lee and col-
leagues [21], we calculated the Revised Cardiac Risk Index
(RCRI) score, assigning one point for each of the following risk
factors: high-risk surgery (defined as intraperitoneal, intratho-
racic, or suprainguinal vascular procedures), ischemic heart
disease, congestive heart failure, cerebrovascular disease
(defined as history of transient ischemic attack or history of
cerebrovascular accident), and diabetes mellitus requiring
insulin therapy.
Patients' demographics, and intraoperative and postoperative
data were collected.
Physiologic data were recorded using customized data entry
forms. Included was Scr that was recorded for each day and
for PACU admission. These data were also recorded 24 hoursAvailable online http://ccforum.com/content/13/3/R79
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before meeting criteria for AKI, at the time of AKI, 24 hours
after AKI, and 48 hours or longer after AKI.
PACU and hospital LOS were also recorded. For mortality we
have registered PACU mortality, hospital mortality, and mortal-
ity at six months after PACU discharge.
Statistical analysis
Descriptive analyses of variables were used to summarize data
and the Mann-Whitney U test was used to compare continu-
ous variables; Chi-squared or Fisher's exact test were used to
compare proportions between two groups of subjects.
To evaluate the determinants of postoperative AKI and to iden-
tify independent predictors of hospital mortality univariate anal-
ysis were performed using simple binary logistic regression
with an odds ratio (OR) and 95% confidence interval (CI) with
the following independent variables: age, gender, BMI, ASA-
PS, type of surgery, comorbidities, RCRI score, type of anaes-
thesia, intraoperative fluid administration, troponin I blood lev-
els at admission, length of anaesthesia, and temperature at
admission (and AKI for mortality model). To reduce the risk of
a type II error we have controlled the significance level for mul-
tiple comparisons applying the Bonferroni's correction for mul-
tiple comparisons (test-wise significance level divided by the
number of tests performed). All variables were deemed to be
significant if P ≤ 0.002.
Multiple regression binary logistic with forward conditional
elimination was used to examine covariate effects of each fac-
tor on AKI and to identify independent predictors of hospital
mortality. In these models covariates with a univariate P  ≤
0.002 in the respective univariate analysis were entered
(applying the Bonferroni's correction for multiple compari-
sons).
Data were analyzed using SPSS for Windows version 16.0
(SPSS, Chicago, IL, USA).
Results
A total of 1597 patients were admitted to the PACU during the
study period and 1166 patients met the inclusion criteria and
were followed for the development of AKI after PACU admis-
sion. One-hundred and twenty-one patients were excluded
because they had abnormal renal function preoperatively
(defined as Scr higher than 1.6 mg/dL for men and 1.4 mg/dL
for women); 196 were excluded because they stayed less than
12 hours and did not had an overnight admission in the PACU;
52 were excluded because they were less than 18 years of
age; 44 were admitted more than once to the PACU and
therefore excluded; 12 were excluded because they were not
surgical patients; and 6 had no preoperative Scr measurement
and were excluded.
The remaining 1166 were followed for the development of AKI
after PACU admission. Eighty-seven (7.5%) developed AKI.
The characteristics of patients with and without AKI are sum-
marized in Table 1. Patients with AKI were older (median age
68 versus 64 years, P = 0.002), had lower BMI (median 24
versus 25, P = 0.020), were more likely to have been submit-
ted for general anesthesia (85% versus 80%, P = 0.004), had
higher troponin I at admission (0.18 ± 0.52 versus 0.06 ±
0.29, P = 0.011), were more likely to have been submitted to
emergency surgery (33% versus 19%, P = 0.001) or high risk
surgery (72% versus 43%, P < 0.001), had more frequently
ischemic heart disease (38% versus 23%, P = 0.001) and
congestive heart disease (46% versus 18%, P < 0.001), were
m o r e  l i k e l y  t o  b e  A S A - P S  I V / V  ( 2 2 %  v e r s u s  5 % ,  P  <
0.001)and have RCRI scores of more than 2 (74% versus
62%, P < 0.001), and had higher volume of intraoperative flu-
ids administered (3.0 ± 2.3 versus 2.6 ± 1.7, P = 0.021 for
crystalloids; 0.3 ± 0.5 versus 0.2 ± 0.4, P = 0.014 for colloids;
1.2 ± 2.6 versus 0.7 ± 1.5, P = 0.003 for units of erythrocytes;
0.6 ± 1.5 versus 0.2 ± 1.0, P = 0.004 for units of fresh frozen
plasma).
Table 2 shows the severity of disease scores and outcome for
patients with and without AKI. Patients with AKI were more
severely ill (median SAPS II 29 versus 18, P < 0.001 and
median APACHE II 12 versus 7, P < 0.001), and stayed longer
in the PACU (median LOS 38 versus 25, P < 0.001). For the
six months follow-up we obtained the postoperative vital status
of all patients. The unadjusted mortality rate at six months fol-
low-up of patients with AKI was 36%, nearly four times the
mortality rate of those without AKI (36% versus 10%, P <
0.001). The increased mortality observed among patients with
AKI was even greater for hospital mortality (26%, versus 3%,
P < 0.001), and PACU mortality (17% versus 1%, P < 0.001).
Univariate analysis for determinants of AKI and their relevant P-
values are summarized in Table 3. Univariate analysis identified
the following independent predictors for development of AKI
in the immediate postoperative period (P ≤ 0.002): age (OR
1.03, 95% CI 1.01 to 1.04, P = 0.002), emergency surgery
(OR 2.17, 95% CI 1.36 to 3.49, P = 0.001), ASA-PS (OR
5.41, 95% CI 3.03 to 9.65, P  < 0.001 for ASA-PS IV/V
patients), high-risk surgery (OR 3.47, 95% CI 2.13 to 5.63, P
< 0.001), ischemic heart disease (OR 2.07, 95% CI 1.31 to
3.26, P = 0.002), congestive heart disease (OR 3.91, 95% CI
2.49 to 6.12, P < 0.001), and RCRI score (OR 3.30, 95% CI
2.12 to 5.14, P < 0.001 for RCRI > 2).
Univariate analysis for severity of disease, LOS, and mortality
are summarized in table 4. Severity of disease scores SAPS II
and APACHE II were significantly higher in AKI patients (OR
1.08, 95% CI 1.06 to 1.10, P < 0.001 and OR 1.18, 95% CI
1.14 to 1.23, P < 0.001 respectively). The perioperative onset
of AKI in patients with previously normal renal function was
associated with significantly increased in PACU LOS (ORCritical Care    Vol 13 No 3    Abelha et al.
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1.14, 95% CI 1.06 to 1.21, P < 0.001), higher PACU mortality
(OR 27.89, 95% CI 11.45 to 67.96, P < 0.001), higher hos-
pital mortality (OR 14.00, 95% CI 7.60 to 25.79, P < 0.001)
and higher mortality at six months follow-up (OR 5.25, 95% CI
3.24 to 8.51, P < 0.001).
Multiple regression logistic analysis was used to examine cov-
ariate effects of each factor on AKI (Table 5). This regression
model included all variables with statistical significance in the
univariate analysis made for determinants of AKI development.
This analysis showed that significant risk factors for AKI were
ASA-PS (OR 3.94, 95% CI 2.07 to 7.51, P < 0.001, for ASA-
Table 1
Patient characteristics and outcomes
Variable All patients
(n = 1166)
AKI
(n = 87)
Non AKI
n = 1079
P
Age in years, median (IQR) 64 (53 to 73) 68 (57 to 76) 64 (53 to 73) 0.002
Age group, n (%) 0.003
≥65 years 581 (50) 56 (64) 525 (49)
< 65 years 585 (50) 31 (36) 554 (51)
Sex, n (%) 0.470
Male 761 (65) 56 (64) 705 (65)
Female 405 (35) 31 (36) 374 (35)
ASA physical status < 0.001
I/II/III 1094 (94) 68 (78) 1026 (95)
IV/V 72 (6) 19 (22) 53 (5)
Body mass index in Kg/m2, median (IQR) 25 (22 to 28) 24 (22 to 27) 25 (22 to 28) 0.020
General anesthesia, n. (%) 940 (81) 72 (85) 868 (80) 0.004
Duration of anesthesia (min.) median (IQR) 210 (150 to 300) 200 (125 to 300) 210 (150 to 300) 0.772
Temperature at admission on PACU, mean ± sd 35.23 ± 1.31 35.04 ± 1.70 35.25 ± 1.27 0.251
Troponin I at admission, mean ± sd 0.07 ± 0.32 0.18 ± 0.52 0.06 ± 0.29 0.011
Hypertension, n (%) 565 (49) 40 (46) 525 (49) 0.356
Hyperlipidemia, n (%) 338 (29) 24 (28) 314 (29) 0.438
Emergency surgery 231 (20) 29 (33) 202 (19) 0.001
High-risk surgery, n (%) 528 (45) 63 (72) 465 (43) < 0.001
Ischemic heart disease, n (%) 279 (24) 33 (38) 246 (23) 0.001
Congestive heart disease, n (%) 233 (20) 40 (46) 193 (18) < 0.001
Cerebrovascular disease, n (%) 170 (15) 12 (11) 158 (15) 0.490
Insulin therapy for diabetes, n (%) 104 (9) 9 (10) 95 (9) 0.370
Total RCRI < 0.001
≤2 437 (38) 54 (62) 833 (77)
> 2 729 (63) 33 (28) 246 (23)
Intraoperative fluid volume
Chrystaloids (L) (IQR) 2.6 ± 1.8 (1.2 to 3.5) 3.0 ± 2.3 (1.5 to 3.6) 2.6 ± 1.7 (1.2 to 3.4) 0.021
Colloids (L) (IQR) 0.2 ± 0.4 (0 to 0.5) 0.3 ± 0.5 (0 to 0.5) 0.2 ± 0.4 (0 to 0.5) 0.014
Erythrocytes (Units) (IQR) 0.7 ± 1.6 (0 to 1) 1.2 ± 2.6 (0 to 2) 0.7 ± 1.5 (0 to 1) 0.003
Fresh frozen plasma (Units) (IQR) 0.3 ± 1.0 (0 to 0) 0.6 ± 1.5 (0 to 0) 0.2 ± 1.0 (0 to 0) 0.004
AKI = acute kidney injury; ASA = American Society of anesthesiologists, IQR = interquartile range; PACU = post anesthesia care unit; RCRI = 
Revised Cardiac Risk Index; SD = standard deviation.Available online http://ccforum.com/content/13/3/R79
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PS IV/V patients), RCRI (OR 2.45, 95% CI 1.52 to 3.96, P <
0.001 for RCRI > 2), high-risk surgery (OR 3.34, 95% CI 2.02
to 5.33, P < 0.001), and congestive heart disease (OR 2.34,
95% CI 1.42 to 3.88, P = 0.001).
Multiple logistic regression analyses was used to examine cov-
ariate effects of each factor on hospital mortality (Table 6). The
regression model included all variables with statistical signifi-
cance in the univariate analysis for determinants of hospital
mortality. This analysis showed that AKI was an independent
risk factors for hospital mortality (OR 3.12, 95% CI 1.41 to
6.93, P = 0.005) after adjustment for age, ASA-PS, high-risk
surgery, congestive heart failure, emergency surgery, SAPS II,
APACHE II, PACU LOS, RCRI, and AKI. Other independent
predictors of hospital mortality were ASA-PS (OR 5.17, 95%
CI 2.38 to 11.21, P < 0.001, for ASA-PS IV/V patients), high-
risk surgery (OR 2.15, 95% CI 1.02 to 4.53, P = 0.043), con-
gestive heart disease (OR 2.90, 95% CI 1.45 to 5.76, P =
0.002), and SAPS II (OR 1.06, 95% CI 1.03 to 1.08, P <
0.001).
Discussion
We report the incidence of postoperative AKI among patients
with normal preoperative renal function to be 7.5%. This inci-
dence is consistent with that reported among general hospi-
talized patients, ranging from 1 to 5% [1]; although, in other
studies, the incidence of postoperative acute renal failure var-
ies from 1.1 to 17% [1] depending on the definition of acute
renal failure [22]. Acute renal failure remains a medical prob-
lem with a daunting outcome: even the best centres typically
report mortalities of 50 to 80% [23]. Recent epidemiologic
studies demonstrate the wide variation in etiologies and risk
factors [24,25].
Unfortunately, acute renal failure is often unrecognized as def-
initions for the disease range from quantitative and qualitative
alterations in Scr to alterations in urine output and dialysis
requirement. The lack of a universally recognized definition of
ARF has posed a significant limitation contributing to the lack
of clinical success. Recognizing the need for uniform stand-
ards, the Acute Dialysis Quality Initiative group in 2002 pro-
posed consensus recommendations of the Risk, Injury, Failure,
Loss and End-stage kidney disease (RIFLE) criteria for the def-
inition and staging of acute renal failure [10]. The wide interest
sparked by the publication of these criteria demonstrated the
additional need for multidisciplinary collaborative efforts for
clinical and translational research in this area. Consequently,
the AKIN was formed to facilitate the development and execu-
tion of initiatives to ensure the best outcomes for patients with
AKI. As an initial step the AKIN group proposed the term acute
kidney injury to reflect the entire spectrum of acute renal failure
and developed interim diagnostic and staging criteria for AKI.
The diagnostic criteria require a 0.3 mg/dL or a 50% or higher
change in Scr from baseline or a reduction in urine output of
less than 0.5 ml/kg/hr over a six-hour interval, within a 48-hour
period, following adequate volume resuscitation. These crite-
ria were based on accumulating evidence that even small alter-
ations in Scr are associated with severe consequences
[2,10,26] and the RIFLE stage correlated with adverse events
[27]. Validation of these concepts was now provided by the
study of Barrantes and colleagues [13] in a consecutive
cohort of patients admitted to a general medical ICU. The
overall incidence of AKI in this cohort is much higher (25.4 to
44.6%) than described in our current study.
Postoperative AKI remains a leading cause of morbidity, mor-
tality, prolonged hospital stay, and increased hospital cost. In
this study, we have attempted to correlate and predict factors
(preoperative, intraoperative, and early postoperative) predis-
posing to AKI. By doing so, one might be able to predict those
at high risk and interventional measures might be planned in
advance to improve outcome after such a complication,
achieving a better outcome and a more efficient use of hospital
and intensive care resources.
Table 2
Severity of disease scores, PACU and hospital length of stay, and mortality
Variable All patients
(n = 1166)
AKI
(n = 87)
Non AKI
(n = 1079)
P
SAPS II, median (IQR) 18 (12 to 25) 29 (20 to 45) 18 (12 to 24) < 0.001
APACHE II, median (IQR) 8 (5 to 11) 12 (8 to 17) 7 (5 to 10) < 0.001
PACU length of stay (hours), median (IQR) 25 (21 to 46) 38 (22 to 72) 25 (21 to 44) < 0.001
Hospital length of stay (days), median (IQR) 13 (7 to 28) 16 (8 to 32) 13 (7 to 28) 0.793
Mortality in PACU, n (%) 23 (2.0) 17 (17.2) 8 (0.7) < 0.001
Mortality in hospital, n (%) 50 (4.3) 23 (26.4) 27 (2.5) < 0.001
Mortality at six months follow-up, n (%) 134 (11.5) 31 (35.6) 103 (9.5) < 0.001
AKI = acute kidney injury; APACHE II = Acute Physiology and Chronic Health Evaluation; IQR = interquartile range; PACU = post anesthesia care 
unit; SAPS II = Simplified Acute Physiology Score.Critical Care    Vol 13 No 3    Abelha et al.
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We intentionally excluded patients with documented preoper-
atively raised Scr in order to predict AKI among patients with
preoperatively normal renal function, as dictated by a Scr less
than 1.6 mg/dL for men and 1.4 mg/dL for women.
There have been a variety of predictive models developed to
stratify risk in patients undergoing cardiac surgery [3,28] and
there is an important recently published study addressing
renal dysfunction after noncardiac surgery [1]. These studies
identified the incidence and risk factors for postoperative
acute renal failure after surgery using acute renal failure defini-
tions that are more strict and less sensitive for renal insuffi-
ciency than those used in our study for AKI. Most predictors or
determinants we have found in our study are consistent with
Table 3
Univariate analysis for determinants of renal dysfunction
Variable AKI/non AKI Odds ratio (95% CI) P
n = 87/n = 1079
Age 66.9 ± 13.2/61.5 ± 15.5 1.03 (1.01 to 1.04) 0.002
≥65 years 56 (64)/525 (49) 1.91 (1.21 to 3.00) 0.005
< 65 years 31 (36)/554(51) 1
Gender 0.96 (0.61 to 1.51) 0.855
Female 31 (36)/374 (35)
Male 56 (64)/705 (65)
Body mass index, median 24.0 ± 4.3/25.6 ± 5.8 0.94 (0.89 to 1.00) 0.019
Duration of anesthesia (min.) 233 ± 140/230 ± 113 1.00 (0.99 to 1.00) 0.772
General/Combined anesthesia, n. (%) 72 (85)/868 (80) 4.59 (1.43 to 14.71) 0.010
Emergency surgery 29 (33)/202 (19) 2.17 (1.36 to 3.49) 0.001
ASA physical status
II/III 68(78)/1026 (95) 1
IV/V 19 (22)/53 (5) 5.41 (3.03 to 9.65) < 0.001
Temperature at admission 35.1 ± 1.8/35.2 ± 1.3 0.91 (0.78 to 1.07) 0.251
Troponin at admission 0.20 ± 0.57/0.06 ± 0.29 1.81 (0.95 to 3.44) 0.070
Hypertension 40(46)/525 (49) 0.90 (0.58 to 1.39) 0.631
Hyperlipidemia 24 (28)/314(29) 0.93 (0.57 to 1.50) 0.765
High-risk surgery 63 (72)/465 (43) 3.47 (2.13 to 5.63) < 0.001
Ischemic heart disease 33 (38)/246 (23) 2.07 (1.31 to 3.26) 0.002
Congestive heart disease 40 (46)/193 (18) 3.91 (2.49 to 6.12) < 0.001
Cerebrovascular disease 12(14)/158 (15) 0.93 (0.50 to 1.76) 0.829
Insulin therapy for diabetes 9 (10)/95 (9) 1.20 (0.58 to 2.46) 0.628
RCRI
≤2 54 (62)/833 (77) 1
> 2 33 (38)/246 (23) 3.30 (2.12 to 5.14) < 0.001
Intraoperative fluid volume
Crystalloids (L) 3.0 ± 2.3/2.6 ± 1.7 1.14 (1.02 to 1.28) 0.024
Colloids (L) 0.3 ± 0.5/0.2 ± 0.4 1.76 (1.11 to 2.78) 0.016
Erythrocytes (Units) 1.2 ± 2.6/0.7 ± 1.5 1.15 (1.04 to 1.27) 0.005
Fresh frozen plasma (Units) 0.6 ± 1.5/0.2 ± 1.0 1.22 (1.04 to 1.42) 0.012
AKI = acute kidney injury; ASA = American Society of Anesthesiologists; CI = confidence interval; RCRI = Revised Cardiac Risk IndexAvailable online http://ccforum.com/content/13/3/R79
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those described in these studies: emergent surgery, advanced
age, peripheral vascular occlusive disease, and high-risk sur-
gery.
In his study with similar objectives but with different methodol-
ogy Kheterpal and colleagues [1] found seven independent
preoperative predictors for the development of acute renal fail-
ure after noncardiac surgery in patients with previously normal
renal function and four of these predictors were similarly found
in our study: age, emergency surgery, high-risk surgery, and
ischemic heart disease. Beyond these we also found conges-
tive heart disease, ASA-PS, and higher RCRI scores as risk
factors for the development of AKI.
The ASA-PS score, a preoperative evaluation used routinely
for every patient, was never intended to be a perioperative risk
score, but all large-scale studies have suggested that a high
ASA-PS score is one of the best predictors of postoperative
morbidity [29,30]. This indicator itself depends on a more
generic classification of the presence of disease, and in itself
indicates the presence of comorbidities. ASA-PS classifica-
tion is a strong prognostic predictor for the development of
postoperative medical complications for patients in a perioper-
ative setting and in fact in our study, we found that increasingly
severe systemic disease (higher ASA-PS level) is a determi-
nant of AKI.
The RCRI is a prediction tool for major cardiac complications
after noncardiac surgery [21,31]. It was developed for the pre-
diction of cardiac risk based on six independent prognostic
factors: high-risk surgery, ischemic heart disease, congestive
heart disease, history of cerebrovascular disease, insulin ther-
apy for diabetes, and preoperative Scr higher than 2.0 mg/dL.
RCRI score is based on predictors, which independently have
a significant association with cardiovascular events. This is
probably the reason why RCRI score is a predictor of AKI in
immediate postoperative period and the meaning of that could
be that patients with pre-existing cardiovascular disease have
an increased perioperative risk of developing AKI in postoper-
ative period. In the present study, we found that RCRI score
was an independent predictor for development of AKI as well
as some of the factors included in it, showing that they were
independent predictors for AKI.
In fact, to assume that both cardiac and renal complications
are based on ischemic injury to sensitive organs may be a
plausible explanation for RCRI as an index. Even some of the
individualized risk factors that compose it appears as a risk
factor for postoperative renal failure.
We noted congestive heart failure to be an independent pre-
dictor for hospital-acquired AKI as stated by Drawz and col-
leagues [32] and that in an ICU population of the study of
Barrantes and colleagues [13] patients with congestive heart
failure were more likely to develop AKI.
Acute renal injury without the need for renal replacement ther-
apy is associated with increased mortality in critically ill
patients and in postoperative cardiac and noncardiac surgery
Table 4
Univariate analysis for severity of disease, length of stay, and mortality
Variable AKI/non AKI Odds ratio (95% CI) P
n = 87/n = 1079
SAPS II 33.3 ± 18.7/18.9 ± 10.3 1.08 (1.06 to 1.10) < 0.001
APACHE II 13.0 ± 6.8/8.0 ± 4.3 1.18 (1.14 to 1.23) < 0.001
PACU stay (days) 2.8 ± 3.4/1.8 ± 2.1 1.14 (1.06 to 1.21) < 0.001
Hospital stay (days) 25 ± 27/24 ± 32 1.00 (0.99 to 1.01) 0.793
Mortality in the PACU 17 (17)/8 (1) 27.89 (11.45 to 67.96) < 0.001
Mortality in the hospital 23 (26)/27 (3) 14.00 (7.60 to 25.79) < 0.001
Mortality at 6 months 31 (36)/103 (10) 5.25 (3.24 to 8.51) < 0.001
AKI = acute kidney injury; APACHE II = Acute Physiology and Chronic Health Evaluation; CI = confidence interval; PACU = post anesthesia care 
unit; SAPS = Simplified Acute Physiology Score.
Table 5
Multivariate analysis to evaluate covariate effects on AKI 
development
Variable Beta Adjusted OR p
ASA physical status 1.371 3.94 (2.07 to 7.51) < 0.001
RCRI 0.896 2.45 (1.52 to 3.96) < 0.001
High-risk-surgery 1.206 3.34 (2.02 to 5.53) < 0.001
Congestive Heart disease 0.851 2.34 (1.42 to 3.88) 0.001
AKI = acute kidney injury; ASA = American Society of 
Anesthesiologists; RCRI = Revised Cardiac Risk Index.Critical Care    Vol 13 No 3    Abelha et al.
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[1,13,33,34]. Similarly our data suggest a relation between
AKI and increased postoperative mortality after noncardiac
surgery; this increased mortality rate was observed in the
PACU, in the hospital, and at six months after PACU dis-
charge.
Mortality of patients with acute renal failure is high. In the study
by Barrantes and colleagues [13], the authors demonstrated
that critical care patients meeting the definition for AKI similar
to the definition used in our study, had a hospital mortality of
46% and that these patients were three times more likely to
die during hospitalization. Our hospital mortality were lower
(27%) but AKI patients were 13 times more likely to die during
hospitalization and 26 times more likely to die during PACU
stay.
In our study patients with AKI had significantly higher hospital
mortality than patients without AKI. Even when controlled for
other variables with a multiple variable regression analysis, AKI
remains an independent risk factor for hospital mortality. This
is consistent with previous data [1,6,35].
The study by Chertow and colleagues [2] first demonstrated
that a change of Scr 0.3 mg/dL or more at any time during hos-
pitalization was associated with increased mortality. Our
study, using the same definition for AKI used in the study by
Barrantes and colleagues [13], not only supports that such
small changes in creatinine are associated with meaningful dif-
ferences in outcome but also that acute increments of 0.3 mg/
dL in a 48-hour period predict mortality.
As in the previous focused study by Barrantes and colleagues
[13], patients with AKI had a longer duration of PACU stay.
We should note some limitations to our analysis. First, our
study was retrospective in nature; we were unable to identify
and analyse all potential confounding factors. The data were
collected as part of the delivered clinical cares. As a result, the
data reflect the electronic medical record, and no additional
detail is available. Documentation of urine output, the use of
vasoactive substances and hemodynamic stability during sur-
gery was less reliable. In our analysis we could only quantify
volume of intraoperative fluid administration and we were una-
ble to address the complete role of intravenous hydration in
AKI because several data elements involved in the quantifica-
tion of resuscitation volume were not accurately collected in
the medical records. This might be an important aspect of
pathophysiology for AKI development and could not be
included in our analysis.
In the study we do not analyse time points for AKI development
and we did not make exclusion criteria to prevent the admis-
sion of patients with late development of AKI. With this
approach we could have considered AKI that could have been
due to complications other than surgery. We did not assess
other potential consequential effects of AKI and the studied
Table 6
Multivariate regression analysis for predictors of in-hospital mortality
Variable Simple OR P Adjusted* OR (95% CI) Pa
Age group, n (%)
≥65 years 2.69 0.002
< 65 years 1
ASA physical status
I/II/III 1 1
IV/V 15.12 < 0.001 5.17 (2.38 to 11.21) < 0.001
Temperature 0.71 < 0.001
Emergency surgery 4.05 < 0.001
High-risk surgery 3.26 < 0.001 2.15 (1.02 to 4.53) 0.043
Congestive heart disease 6.75 < 0.001 2.90 (1.45 to 5.76) 0.002
SAPS II 1.09 < 0.001 1.06 (1.03 to 1.08) < 0.001
APACHE II 1.27 < 0.001
PACU LOS (days) 1.19 < 0.001
AKI 14.00 < 0.001 3.12 (1.41 to 6.93) 0.005
aLogistic regression analysis with stepwise forward method was used with an entry criterion of P < 0.05 and a removal criterion of P > 0.1.
*Adjusted to age, ASA physical status, high-risk surgery, congestive heart failure, emergency surgery, SAPS II, APACHE II, PACU LOS, and AKI.
AKI = acute kidney injury; APACHE II = Acute Physiology and Chronic Health Evaluation; ASA = American Society of Anesthesiologists; CI = 
confidence interval; LOS = length of stay; OR = odds ratio; PACU = post anesthesia care unit; SAPS = Simplified Acute Physiology Score.Available online http://ccforum.com/content/13/3/R79
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outcomes (mortality and LOS) may not necessarily capture all
relevant consequences of AKI. The mortality data are based on
all-cause mortality and no additional detail regarding the cause
of death are available for review. This may limit the ability to
interpret our data on mortality.
Conclusions
Using the interim consensus definition of AKI we could predict
meaningful clinical outcomes and were able to identify risk fac-
tors for the development of AKI in patients needing intensive
care after surgery.
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